Abstract

BackgroundAs an indispensable marker of complement cascades activation, C4d was confirmed of its crucial role in the pathogenesis of both lupus nephritis (LN) and IgA nephropathy (IgAN). While the studies directly comparing the diagnostic value, and outcomes predicting function of C4d between LN and IgAN are still absent.MethodsA cohort of 120 LN patients, 120 IgAN patients who were diagnosed by renal biopsy between January 2015 and December 2017 and 24 healthy age matched controls were prospectively analyzed. The patients were followed till December 2020. The outcomes were adverse disease treatment response (disease relapse) and kidney disease progression event (decline of estimated glomerular filtration rate by more than 20% or end-stage kidney disease). The renal C4d deposition proportion and pattern were compared between IgAN and LN patients. In addition, the relationship between renal C4d deposition and disease subtypes, disease relapse as well as disease progression for LN and IgAN patients were also analyzed.ResultsThe LN, IgAN patients and healthy controls were well matched in ages. The follow-up period was 38.5 (30.3–60.8) months for LN patients and 45.0 (30.5–57.0) months for IgAN patients. 78 patients (65.0%) with LN had renal C4d deposition, compared with only 39 IgAN patients (32.5%) with C4d deposition in renal tissues (P < 0.001). The LN patients shared different renal C4d distribution patterns with IgAN patients. Compared with IgAN patients, the C4d deposition in LN patients was significantly more in renal glomerulus (P < 0.001) and less in renal tubules (P = 0.003). For disease subtypes, renal C4d deposition was especially strong in class V membranous LN and IgAN with tubulointerstitial fibrosis (T1/T2) lesions. Renal C4d deposition was independently correlated with the disease relapse of LN patients (HR = 1.007, P = 0.040), and acted as an independent predictor of disease progression during the follow-up period for IgAN patients (HR = 1.821, P = 0.040).ConclusionsRenal C4d distribution proportion and pattern differed between LN and IgAN patients. The presence of C4d in renal tissue acted as an independent predictor of relapse for LN patients and disease progression for IgAN patients.

Highlights

  • Systemic lupus erythematosus (SLE) is an autoimmune disease, and up to 60% of SLE patients developed Lupus nephritis (LN) during the course of the disease [1]

  • LN patients with C4d deposition in renal tissue were much more than IgA nephropathy (IgAN) patients (65.0% vs. 32.5%, P < 0.001)

  • Renal C4d deposition was especially strong in class V membranous LN and IgAN with tubulointerstitial fibrosis lesions

Read more

Summary

Introduction

Systemic lupus erythematosus (SLE) is an autoimmune disease, and up to 60% of SLE patients developed Lupus nephritis (LN) during the course of the disease [1]. Complement activation through alternative and lectin pathways might play significant roles in the pathogenesis of IgAN via upregulating local inflammatory responses and glomerular injury [6, 7]. Both LN and IgAN are immune complex-mediated diseases, the pathogenesis, their etiologies, and the therapeutic strategies are different. Shared genetics between immune-related diseases may account for this in some extent [11] In this case, it is significant to find a reliable screening and diagnostic tool to differentiate the renal disease in SLE patients between LN and IgAN, which has important implications on therapeutic regimens to be adopted, and further influences the disease prognosis in both short and long term. While the studies directly comparing the diagnostic value, and outcomes predicting function of C4d between LN and IgAN are still absent

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call